Register entry
Sucampo Pharma Americas, LLC
- Registered sites
- 2
- Drug products
- 0
- Live patents
- 6
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| SUCAMPO PHARMA LIMITED LIABILITY COMPANY | KOBEJapan | Analytical testing | 3009036781 |
| SUCAMPO PHARMA LIMITED LIABILITY COMPANY | SANDAJapan | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3004520523 |
Exclusivity
Patents
6Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| AMITIZA | LUBIPROSTONE | Jan 2027 |
| AMITIZA | LUBIPROSTONE | Oct 2027 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.